Psychiatrists and mental health professionals have a new standard for managing major depression, thanks to refreshed clinical guidelines published today by UBC researchers at the Canadian Network for Mood and… Read More
KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces that human pilot study #2, GLP-1-H24-2, (the “Study”) is underway and… Read More
QULIPTA is now the first and only oral calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) approved to prevent migraine across all frequencies, including episodic and chronic. Expanded indication provides an… Read More
BURLINGTON, NC & SAN FRANCISCO, CA – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Invitae (OTC:NVTAQ), a leading medical genetics company, announced that the United… Read More
TORONTO, ON – BeiGene Canada, the country affiliate of global oncology company BeiGene, specializing in the discovery and development of novel, affordable, and accessible oncology medications, has opened its first office in Canada…. Read More
